Experimental hepatitis c vaccine enters first human safety trial
NCT ID NCT07237282
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial will test an experimental vaccine against hepatitis C (HCV) in 27 healthy adults. The main goal is to see if the vaccine is safe and to measure the immune response it triggers. Participants will receive three shots over 24 weeks and be closely monitored for side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AVIHepC1 (experimental HCV vaccine with adjuvant)
What this could lead to
If successful, this could pave the way for a vaccine to prevent hepatitis C infection.
What could go wrong
This is a very early phase 1 trial with only 27 healthy adults, focused on safety. It is too soon to know if the vaccine will actually prevent infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS C are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ottawa Hospital - General Campus
Ottawa, Ontario, K1H 8L6, Canada
Contact
-
Toronto General Hospital - Toronto Centre for Liver Disease
Toronto, Ontario, M5G 2C4, Canada
Contact
-
University of Alberta Hospital
Edmonton, Alberta, T6G 2B7, Canada
Contact